OxyContin, in 80 mg pills, in a 2013 file image. (Liz O. Baylen/Los Angeles Times/TNS)

OxyContin, in 80 mg pills, in a 2013 file image. (Liz O. Baylen/Los Angeles Times/TNS)

Senate passes $6.3 billion medical research bill and sends to Obama

WASHINGTON — Sprawling legislation to increase federal support for medical research, mental health care and controlling the opioid epidemic cleared the Senate easily Wednesday and is headed to President Barack Obama’s desk for his signature, delivering a rare bipartisan breakthrough in the waning days of his presidency.

The $6.3 billion bill — known as the 21st Century Cures Act — won large majorities in the House and Senate despite warnings from some consumer groups that industry-sought provisions to speed approval of new drugs and medical devices jeopardize patient safety.

Obama, who strongly endorsed the bill, said it “could help unlock cures (for) Alzheimer’s, end cancer as we know it, and help people seeking treatment for opioid addiction finally get the help they need.”

The 94-4 Senate vote followed several years of lobbying by patient advocates and powerful industries, including drug manufacturers. The bill cleared the House last week by a 392-26 vote.

“Finding solutions for deadly and debilitating health threats and combating insidious public health threats should be a dual imperative for our nation, and this legislation could well usher in an era of unprecedented progress on both fronts,” said Mary Woolley, president of Research!America, a coalition of more than 350 academic research organizations, disease advocacy groups, drug makers and other industries.

The bill would provide $4.8 billion to the National Institutes of Health to support research efforts, such as the so-called Cancer Moonshot initiative championed by Vice President Joe Biden.

Food and Drug Administration will receive an additional $500 million to streamline its review of new drug therapies.

The legislation also advances federal initiatives that have languished for years, including new funding sought by public health departments to combat the opioid epidemic.

Other parts of the bill would support steps designed to strengthen the nation’s mental health system by coordinating treatment research, supporting community efforts to reduce homelessness and keeping mentally ill patients out of the criminal justice system.

Advocates say substantial additional funding is needed beyond what is provided in the bill.

The legislation has generated concerns among many consumer advocates, who have warned that provisions that would speed federal regulatory review of new drugs and medical devices could expose patients to new risks.

“The bill has been sold erroneously as a common sense, bipartisan compromise that enables scientific innovation and medical breakthroughs for America,” said Dr. Michael Carome, director of Public Citizen’s Health Research Group. “But in reality, the legislation includes a grab bag of goodies for Big Pharma and medical device companies that would undermine requirements for ensuring safe and effective drugs and medical devices.”

Several leading liberal lawmakers have also blasted the legislation for including what Sen. Bernie Sanders, I-Vt., last week called “corporate giveaways that will make drug companies even richer.”

The White House acknowledged that it has issues with parts of the legislation, but Obama noted that the tradeoffs were worth it.

“Like all good legislation, it reflects compromise,” the president said during his weekly radio address Saturday.

Hospitals and insurance companies successfully lobbied for the bill to include provisions shielding them from cuts in what the federal Medicare program pays them.

Another provision favored by industry would exempt some payments that physicians receive from drug and device makers from federal reporting requirements designed to alert patients to potential conflicts of interest.

Conservative activist group Heritage Action for America opposed the bill because it will add to federal spending.

The bill’s spending is offset with cuts in Medicare payments for drug therapies and medical equipment, other spending reductions and the sale of 25 million barrels of oil from the nation’s strategic petroleum reserve.US

Just Posted

ose Pak and Willie Brown at an event in 2014. 
Rose Pak and Willie Brown at an event in 2014.
Willie and Rose: An alliance for the ages

How the Mayor and Chinatown activist shaped San Francisco, then and now

San Francisco supervisors are considering plans to replace trash cans — a “Renaissance” garbage can is pictured on Market Street — with pricey, unnecessary upgrades. (Kevin N. Hume/The Examiner)
San Francisco must end ridiculous and expensive quest for ‘pretty’ trash cans

SF’s unique and pricey garbage bins a dream of disgraced former Public Works director

Giants right fielder Mike Yastrzemski is pictured at bat on July 29 against the Dodgers at Oracle Park; the teams are in the top spots in their league as the season closes. (Chris Victorio/Special to The Examiner)
With playoff positions on the line, old rivalries get new life

Giants cruised through season, Dodgers not far behind

Golden Gate Park visitors may take a survey about options regarding private car access on John F. Kennedy Drive, which has been the subject of controversy during the pandemic.<ins> (Kevin N. Hume/S.F. Examiner)</ins>
Your chance to weigh in: Should JFK remain closed to cars?

Host of mobility improvements for Golden Gate Park proposed

Drivers gathered to urge voters to reject an initiative that would exempt Uber, Lyft, and other gig economy companies from state labor laws, in San Francisco in October 2020. (Jim Wilson/New York Times)
What’s the role of unions in the 21st century?

As membership declines in California, economic inequality increases

Most Read